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Abstract 
 
Acute and chronic toxicities of the water extract from calyces of Hibiscus sabdariffa were studied in male and 
female rats. After 14 days of a single oral administration of test substance 5,000 mg/kg body weight, measurement of the 
body and organ weights, necropsy and health monitoring were performed. No signs and differences of the weights or 
behaviour compared to the control rats were observed. The results indicated that the single oral administration of H. 
sabdariffa extract in the amount of 5,000 mg/kg body weight does not produce acute toxicity. The chronic toxicity was 
determined by oral feeding both male and female rats daily with the extract at the doses of 50, 100, and 200 mg/kg body 
weight for 270 days. The examinations of signs, animal behaviour and health monitoring showed no defects in the test groups 
compared to the control groups. Both test and control groups (day 270th) and satellite group (day 298th) were analysed by 
measuring their final body and organ weights, taking necropsy, and examining haematology, blood clinical chemistry, and 
microanatomy. Results showed no differences from the control groups. Overall, our study demonstrated that an oral 
administration of H. sabdariffa extract at the doses of 50, 100 and 200 mg/kg body weight for 270 days does not cause 
chronic toxicity in rat. 
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Introduction  
 
Hibiscus sabdariffa L. (family Malvaceae) is a plant found in many countries, and is commonly known as Roselle. 
The calyces have been used in folk medicines and claimed to be effective as antimicrobial, antiseptic, astringent, digestive, 
diuretics, hypertension, laxative, sedative, and stomachic (Perry, 1980), and used for treatment of pyrexia and liver disease 
(Mahadevan et al., 2009). The calyces contain a number of flavonoids gossypetin, hibiscetine and sabdaretine, ascorbic acid, 
mucilage, calcium citrate, etc. (Mahadevan et al., 2009).  
Many studies have shown the pharmacological activities of H. sabdariffa. These include decreasing blood pressure 
in spontaneously hypertensive rats (Odigie et al., 2003; Onyenekwe et al., 1999; Adegunloye et al., 1996) as well as in 
patients with essential hypertension (Herrera-Arellano et al., 2004; Faraji and Tarkhani, 1999). H. sabdariffa extract was 
found to protect human erythrocytes against lipid peroxidation (Suboh et al., 2004). In addition, H. sabdariffa extract lowered 
serum lipids and showed an anti-atherosclerotic activity in cholesterol-fed rabbits and rats (Chen et al., 2003). The water and 
ethanolic extracts of H. sabdariffa have natural phenols content, antioxidant and antibacterial activity (Al-Hashimi, 2012).  
The toxicity profiles of H. sabdariffa have been reported previously. In the acute toxicity test, no toxicity was 
observed within 7 days after oral administration at the high dose of 15 g/kg ethanol and aqueous extracts of H. sabdariffa 
calyces in mice (Reanmongkol and Itharat, 2007).  The prolonged usage at 15-dose level of the aqueous-methanolic extract of 
H. sabdariffa calyces at the dose of 250 mg/kg could cause liver injury in rats (Akindahunsi and Olaleye, 2003). The 
subchronic effect (12 weeks) of H. sabdariffa calyx aqueous extract at the doses of 1.15, 2.30, and 4.60 g/kg induced 
testicular toxicity (Orisakwe et al., 2004). Moreover, a 90-day oral administration in albino rats of water and alcohol extracts 
of dried calyx of H. sabdariffa at a dose of 2,000 mg/kg caused the death of the animals, preceded by a severe loss in weight 
accompanied with diarrhoea (Fakeye et al, 2009). Although, H. sabdariffa is long used in traditional medicines, the chronic 
toxicity study of water extract has never been determined. This study was aimed at evaluating the safety of the water extract 
from the calyces of H. sabdariffa by single and long-term oral administration in rats. 
 
 
Materials and methods 
Plant material and preparation of the water extract from the calyces of H. sabdariffa  
 
Red calyces of H. sabdariffa L. were collected at Khounmeet District in Songkhla Province, Thailand. The plant 
was identified by a direct comparison with herbarium specimens in the PSU Herbarium, Department of Biology, Faculty of 
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Sciences, Prince of Songkla University. A voucher specimen No. SKP109 08 10 01 of plant material has been deposited in 
the Faculty of Pharmaceutical Sciences, Prince of Songkla University, Thailand. The dried calyces of H. sabdariffa were 
extracted in hot water (70C) and then filtered. The filtrates were evaporated using vacuum drying (40C) under reduced 
pressure to give the aqueous extracts. This extract was stored at 4-5 C after preparation. 
 
Animals 
 
Male and female Sprague-Dawley (SD) rats (190-220 g) were obtained from the National Laboratory Animal 
Center, Nakorn Pathom, Thailand. All animals were kept in the room, maintained under environmentally controlled 
conditions of 25 ± 1C and 12 h light-12 h dark cycle. Food and water were available freely. All experimental protocols were 
approved by the Animal Ethics Committee of Faculty of Medicine, Thammasat University (No. 0006/2007). 
 
Acute toxicity test 
 
Forty SD rats, twenty males and twenty females, were used and divided into control and test groups. Before 
experiment, all rats were fasted overnight with free access to water. Ten males and ten females were administered orally with 
the water extract of H. sabdariffa at the single dose of 5,000 mg/kg. The control rats received distilled water. The sign of 
toxicity and death were observed over 2 weeks. During the experiment, food and water were available freely (Figure 1).  
 
 
Figure 1 Scheme for Acute Toxicity Test of H. sabdariffa L. Extract 
 
Chronic toxicity test 
 
One hundred rats were divided into control and four test groups, 20 in each group (ten males and ten females). The 
animals were treated with distilled water and the extract at the doses of 50, 100, and 200 mg/kg daily for 270 days. The 
satellite group was administered orally with the extract at the dose of 200 mg/kg daily for 270 days and kept for another 28 
days after the treatment in order to detect a delayed occurrence of toxic effect. Food and water were available freely during 
the experiment. The appearance of signs of toxicity, behavioural alterations, respiratory pattern, cardiovascular signs, motor 
activities, reflexes, change in skin and fur and mortality was observed and recorded. The body weight of rat was measured 
each week (Figure 2). 
At the end of experiment, the rats were fasted 12 hours, and then sacrificed with the overdose of pentobarbital 
sodium (100 mg/kg, intraperitoneal injection). Their blood was collected from a common carotid artery with heparinised 
tubes. Red blood cell (RBC), haemoglobin (HB), haematocrit (HCT), mean corpuscular volume (MCV), mean corpuscular 
haemoglobin (MCH), mean corpuscular haemoglobin concentration (MCHC), platelet (PLT), white blood cell (WBC), 
neutrophil (PMN), lymphocyte (LYMP), monocyte (MONO), eosinophill (EOS), and basophill (BASO) were detected by 
Sysmex K-1000 Fully Automated Haematology Analyser.  
The serum was separated and we measured the levels of glucose (GLU), blood urea nitrogen (BUN), creatinine 
(CRE), total protein (TP), albumin (ALB), total bilirubin (T-BIL), direct bilirubin (D-BIL), total cholesterol (CHO), 
triglyceride (TG), serum glutamic-oxaloacetic transaminase (SGOT), serum glutamic-pyruvic transaminase (SGPT), and 
alkaline phosphatase (ALP), using the COBAS INTEGRA System. 
The internal organs (brain, thymus, heart, lungs, livers, kidneys, spleen, adrenal glands, pancreas, small intestine, 
stomach and duodenum, muscle with sciatic nerve, thoracic spines, eyes, ovary, uterus, testis, and epididymis) were removed, 
weighted and observed for gross lesions. All tissues were preserved in 10% neutral buffered formaldehyde solution. Samples 
of the internal organs were dehydrated by serial ethanol solution and enclosed with paraffin. Micrometer sections (5 μm) cut 
with microtome was stained with haematoxylin and eosin (H&E) and examined under a light microscope. Photomicrographs 
of the samples were recorded. 
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Figure 2 Scheme for Chronic Toxicity Test of H. sabdariffa L. 
 
Statistical analysis 
 
The values were expressed as mean ± standard error of mean (S.E.M.). The statistics included one-way analysis of 
variance (ANOVA), Dunnett’s test, and Student’s t-test. P < 0.05 was considered statistically significant. 
 
 
 
Results and discussion 
 
In this present study, an acute toxicity study of H. sabdariffa extract has been performed. A single administration of 
H. sabdariffa extract by the oral route up to a dose of 5000 mg/kg did not produce mortality, any signs of toxicity or changes 
in general behaviour or other physiological activities when compared with the control group. Moreover, the body weight and 
internal organ weight of treated rats were relatively similar to that of the control group. Additionally, gross and pathological 
examinations of the internal organs revealed no pathological abnormalities. According to the OECD guideline (2001), the 
result of acute toxicity test in this study indicated that H. sabdariffa extract has no acute oral toxicity. 
While acute toxicity deals with the adverse effects of single doses, many chemical substances in the form of 
repeated doses do not produce immediate toxic effects. Delayed effects may occur due to accumulation of the chemical in 
tissues or to other mechanisms. Thus, it is important to identify any toxic potential of the substance by a chronic toxicity test. 
The use of a satellite group of test animals, given the highest dose and then observed after the ending of dosing, is to give 
additional information on the persistence or reversibility of effects (OECD, 1981). This study provides information on toxic 
effect, target organs, reversibility or a “no effect level”. 
The administration of H. sabdariffa extract at a dose of 50, 100, and 200 mg/kg daily for 270 days caused neither 
any toxicity sign, abnormalities in behaviours nor death in rats. At day 270, we detected the significantly decreased body 
weights of the female rats receiving extract at 50, 100, 200 mg/kg, that of the male rats receiving 200 mg/kg, as well as the 
male treated satellite group (Table 1). The weights of liver of the female group treated with 50 and 100 mg/kg were 
significantly less than those of the control group (Table 2). In the male groups treated with 50, 100 and 200 mg/kg showed 
significant decrease in the kidney weight. Moreover, H. sabdariffa extract at a dose of 200 mg/kg significantly reduced the 
liver weight (Table 2). Nonetheless, these effects on the organ weight (liver and kidney) were normal due to organs’ size 
and/or weight variation of animals. Therefore, the extract likely did not affect the animal organs.  
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Table 1: Effect of H. sabdariffa extract on body weight of female and male rats 
Body weight (g)   Dose 
(mg/kg) Day 0 Day 90 Day 180 Day 270 
Female      
Control   - 198.0 ± 4.1 296.0 ± 7.8 319.5 ± 6.9 356.5 ± 9.5 
  50 204.5 ± 1.4 287.0 ± 5.6 307.5 ± 4.0 329.5 ± 7.2* 
  100 199.5 ± 2.3 283.5 ± 4.9 302.0 ± 7.0* 331.5 ± 11.8* 
  200 a 193.5 ± 4.8 282.0 ± 4.4 309.0 ± 5.5 324.0 ± 4.6* 
H. sabdariffa 
extract 
  200 b 200.5 ± 3.0 283.5 ± 4.5 315.5 ± 5.2 340.0 ± 7.7 
Male      
Control    - 212.0 ± 4.6 456.5 ± 9.7 519.5 ± 10.9 571.0 ± 13.0 
  50 212.0 ± 4.8 461.0 ± 9.2 522.0 ± 10.8 578.5 ± 14.4 
  100 209.0 ± 3.0 449.0 ± 6.9 502.5 ± 5.6 545.5 ± 7.3 
  200 a 209.5 ± 3.7 440.5 ± 4.6 487.5 ± 6.2* 528.0 ± 7.8* 
H. sabdariffa 
extract 
  200 b 202.0 ± 4.4 418.0 ± 9.9* 470.0 ± 11.6* 508.5 ± 14.3* 
Values are expressed as mean ± S.E.M., n = 10 
*Significantly different from control, p<0.05 
 
 
Table 2: Effect of H. sabdariffa extract on organ weights of rats  
  H. sabdariffa extract 
 Control 50 mg/kg 100 mg/kg 200 mg/kg Satellite 
Female  
Lung  1.4 ± 0.0 1.4 ± 0.0 1.5 ± 0.0 1.4 ± 0.1 1.6 ± 0.1 
Heart 1.1 ± 0.0 1.1 ± 0.0 1.1 ± 0.0 1.1 ± 0.0 1.19 ± 0.0 
Liver 8.9 ± 0.4 7.8 ± 0.2* 8.1 ± 0.3* 8.2 ± 0.2 8.8 ± 0.2 
Pancreas  1.2 ± 0.0 1.4 ± 0.1 1.2 ± 0.1 1.4 ± 0.0 1.4 ± 0.1 
Spleen  0.8 ± 0.0 0.8 ± 0.0 0.8 ± 0.0 0.8 ± 0.0 0.8 ± 0.0 
Kidney  1.2 ± 0.0 1.1 ± 0.0 1.1 ± 0.0 1.1 ± 0.0 1.2 ± 0.0 
Ovary  0.1 ± 0.0 0.1 ± 0.0 0.0 ± 0.0 0.1 ± 0.0 0.1 ± 0.0 
Brain 2.0 ± 0.1 1.9 ± 0.0 1.9 ± 0.0 1.9 ± 0.0 2.0 ± 0.0 
Male 
Lung  2.0 ± 0.1 2.2 ± 0.2 1.8 ± 0.0 2.0 ± 0.0 1.9 ± 0.1 
Heart 1.6 ± 0.0 1.5 ± 0.1 1.6 ± 0.0 1.6 ± 0.0 1.5 ± 0.0 
Liver 14.8 ± 0.3 14.9 ± 0.5 13.9 ± 0.3 13.5 ± 0.3* 14.5 ± 0.4 
Pancreas  1.6 ± 0.1 1.6 ± 0.1 1.7 ± 0.1 1.6 ± 0.1 1.5 ± 0.1 
Spleen  1.0 ± 0.0 1.0 ± 0.0 1.0 ± 0.0 1.0 ± 0.0 1.0 ± 0.0 
Kidney  1.8 ± 0.0 1.6 ± 0.0* 1.6 ± 0.0* 1.6 ± 0.0* 1.7 ± 0.0 
Testis   2.0 ± 0.0 2.0 ± 0.0 2.0 ± 0.0 1.9 ± 0.0 2.0 ± 0.0 
Epididymis  0.9 ± 0.0 0.9 ± 0.0 0.8 ± 0.0* 0.8 ± 0.0 0.9 ± 0.0 
Brain  2.0 ± 0.0 2.1 ± 0.0 2.0 ± 0.0 2.0 ± 0.0 2.0 ± 0.0 
Values are expressed as mean ± S.E.M., n = 10 
*Significantly different from control, p<0.05 
 
Haematological examination revealed a significantly higher level of WBC in the treated group at the dose of 50 mg/kg and 
the satellite group. Significant decrease in the MCV of female and male rats, but increases in both the MCHC of female rats 
and the RBC of male rats were observed (Table 3). These parameters are useful as the RBC indices for differential diagnosis 
of anaemia (Voigt, 2000). However, these values detected are still within the normal range of SD rats (Inala et al., 2002). 
Blood chemistry test is used to assess a wide range of conditions and the function of organs, especially the 
pancreas, liver and kidneys. In general, if the clinical blood chemistry values differ more or less than one fold from the 
normal values, the abnormality of these organs should be noted accordingly (Caisey and King, 1980; Sacher and McPherson, 
2000). In our study, the clinical blood chemistry values indicated significant increases in the levels of plasma BUN and 
SGOT in the female rats treated with the extract at the dose of 50 mg/kg. The level of SGPT was significantly increased in 
the rat treated with 200 mg/kg. The amounts of TP and ALB were significantly decreased in the female satellite group (Table 
4). The satellite group of male rats significantly showed increased level of GLU, but decreased levels of CHO and TP (Table 
5). Although some clinical blood chemistry values were significantly changed in the extract-treated rats, these parameters are 
still within the normal range (Angkhasirisap et al., 2002). These results suggested that H. sabdariffa extract does not cause 
damages in the pancreas, liver or kidney, as confirmed by the pathological examination. 
 
 
Conclusion 
 
The water extract of H. sabdariffa calyces administered orally did not cause acute or chronic toxicities in both 
female and male rats. These results suggest the acute and long-term safety of H. sabdariffa. 
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Table 3: Effect of H. sabdariffa extract on haematological values of rats 
  H. sabdariffa extract 
 Control 50 mg/kg 100 mg/kg 200 mg/kg Satellite 
Female      
RBC (x106/l) 7.3 ± 0.1 7.2 ± 0.1 7.3 ± 0.1 7.3 ± 0.2 7.3 ± 0.1 
HB (g/dl) 14.8 ± 0.1 14.7 ± 0.2 14.6 ± 0.2 15.0 ± 0.3 14.9 ± 0.2 
HCT (%) 44.6 ± 0.5 43.7 ± 0.8 43.8 ± 0.7 43.7 ± 1.1 43.6 ± 0.5 
MCV (fl) 60.6 ± 0.2 60.0 ± 0.3 59.5 ± 0.4* 59.7 ± 0.6 59.3 ± 0.3* 
MCH (pg) 20.1 ± 0.1 20.4 ± 0.2 19.9 ± 0.1 20.5 ± 0.3 20.3 ± 0.2 
MCHC (g/dl) 33.1 ± 0.2 34.0 ± 0.3 33.5 ± 0.2 34.3 ± 0.5* 34.2 ± 0.3* 
PLT (x105/l) 6.8 ± 0.3 7.2 ± 0.2 6.6 ± 0.3 7.2 ± 0.5 6.6 ± 0.1 
WBC (x103/l) 2.1 ± 0.3 2.4 ± 0.3 2.0 ± 0.3 2.4 ± 0.3 1.8 ± 0.2 
Male      
RBC (x106/l) 8.1 ± 0.1 8.0 ± 0.2 8.4 ± 0.1 8.2 ± 0.1 8.4 ± 0.1* 
HB (g/dl) 15.5 ± 0.1 15.6 ± 0.2 15.9 ± 0.2 15.9 ± 0.2 15.8 ± 0.2 
HCT (%) 47.1 ± 0.4 47.4 ± 0.7 48.4 ± 0.6 47.7 ± 0.5 47.8 ± 0.8 
MCV (fl) 58.4 ± 0.5 59.0 ± 0.5 57.5 ± 0.3 58.4 ± 0.5 56.5 ± 0.2* 
MCH (pg) 19.2 ± 0.2 19.4 ± 0.3 18.9 ± 0.1 19.5 ± 0.2 18.8 ± 0.3 
MCHC (g/dl) 32.9 ± 0.2 32.8 ± 0.3 32.9 ± 0.1 33.4 ± 0.2 33.3 ± 0.6 
PLT (x105/l) 7.9 ± 0.2 8.2 ± 0.2 7.9 ± 0.2 7.9 ± 0.1 7.4 ± 0.2 
WBC (x103/l) 3.1 ± 0.3 3.8 ± 0.3* 3.3 ± 0.2 3.4 ± 0.2 4.0 ± 0.3* 
Values are expressed as mean ± S.E.M., n = 10 
*Significantly different from control, p<0.05 
 
 
Table 4: Effect of H. sabdariffa extract on blood chemical values of female rats 
  H. sabdariffa extract 
 Control 50 mg/kg 100 mg/kg 200 mg/kg Satellite 
GLU (mg/dl)  127.9 ± 3.5 131.6 ± 4.0 131.6 ± 3.4 128.3 ± 4.3 133.9 ± 4.6 
BUN (mg/dl) 21.5 ± 0.9 24.0 ± 0.8* 23.4 ± 0.7 23.0 ± 0.8 21.6 ± 0.6 
CRE (mg/dl) 0.4 ± 0.0 0.5 ± 0.0 0.4 ± 0.0 0.4 ± 0.0 0.4 ± 0.0 
CHO (mg/dl)  91.5 ± 3.6 87.2 ± 4.2 88.8 ± 5.3 89.6 ± 3.2 90.3 ± 4.0 
TRI (mg/dl) 59.5 ± 4.1 58.4 ± 4.7 64.6 ± 7.7 61.4 ± 6.3 58.1 ± 2.7 
TP (g/dl)  6.2 ± 0.1 6.1 ± 0.1 6.3 ± 0.2 6.0 ± 0.2 5.7 ± 0.1* 
ALB (g/dl) 4.3 ± 0.1 4.2 ± 0.1 4.2 ± 0.1 4.1 ± 0.1 3.9 ± 0.1* 
T-BIL (mg/dl) 0.3 ± 0.0 0.2 ± 0.0 0.2 ± 0.0 0.2 ± 0.0 0.3 ± 0.0 
D-BIL (mg/dl) 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 
SGOT (U/l) 172.2 ± 10.5 229.9 ± 29.4* 156.6 ± 11.9 223.4 ± 21.1 184.2 ± 10.9 
SGPT (U/l) 51.5 ± 5.3 76.6 ± 12.6 51.3 ± 3.9 90.3 ± 21.8* 53.7 ± 4.9 
ALP (U/l) 34.2 ± 1.6 31.6 ± 1.8 31.3 ± 1.6 30.0 ± 2.2 33.3 ± 1.7 
Values are expressed as mean ± S.E.M., n = 10. 
*Significantly different from control, p<0.05 
 
 
 
Table 5: Effect of H. sabdariffa extract on blood chemical values of male rats 
  H. sabdariffa extract 
 Control 50 mg/kg 100 mg/kg 200 mg/kg Satellite 
GLU (mg/dl)  135.2 ± 2.5 131.5 ± 2.8 138.3 ± 3.4 131.2 ± 3.2 146.0 ± 3.3* 
BUN (mg/dl) 20.2 ± 0.5 21.9 ± 1.5 21.9 ± 0.7 21.4 ± 1.0 20.7 ± 0.8 
CRE (mg/dl) 0.4 ± 0.0 0.4 ± 0.0 0.4 ± 0.0 0.4 ± 0.0 0.4 ± 0.0 
CHO (mg/dl)  114.4 ± 3.5 117.0 ± 3.4 116.5 ± 3.7 113.3 ± 3.2 101.2 ± 1.9* 
TRI (mg/dl) 50.2 ± 3.9 58.9 ± 2.8 57.7 ± 3.3 54.1 ± 4.2 47.5 ± 2.5     
TP (g/dl)  6.0 ± 0.1 6.2 ± 0.1 6.2 ± 0.0 6.1 ± 0.1 5.7 ± 0.1* 
ALB (g/dl) 3.7 ± 0.1 3.7 ± 0.1 3.7 ± 0.0 3.7 ± 0.1 3.6 ± 0.1     
T-BIL (mg/dl) 0.2 ± 0.0 0.2 ± 0.0 0.2 ± 0.0 0.2 ± 0.0 0.2 ± 0.0 
D-BIL (mg/dl) 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 
SGOT (U/l) 174.8 ± 14.6 191.9 ± 18.7 183.2 ± 13.4 206.0 ± 27.2 157.2 ± 27.0 
SGPT (U/l) 56.6 ± 4.1 50.4 ± 2.6 57.9 ± 3.7 62.8 ± 9.1 69.1 ± 15.6 
ALP (U/l) 49.4 ± 2.3 55.0 ± 2.3 55.8 ± 2.2 55.1 ± 1.7 50.5 ± 3.7 
Values are expressed as mean ± S.E.M., n = 10 
*Significantly different from control, p<0.05 
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